Jennison Associates LLC Karuna Therapeutics, Inc. Transaction History

Jennison Associates LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 31, 2023	BUY	$164.66 - $218.08 $6.73 Million - $8.92 Million	40,880 Added 89.28%	86,670 $14.7 Million
Q2 2023 Aug 03, 2023	BUY	$176.32 - $240.22 $8.07 Million - $11 Million	45,790 New	45,790 $9.93 Million
Q2 2022 Aug 02, 2022	SELL	$93.97 - $143.33 $25.7 Million - $39.2 Million	-273,540 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$98.9 - $132.37 $9.23 Million - $12.3 Million	93,290 Added 51.76%	273,540 $34.7 Million
Q4 2021 Feb 08, 2022	BUY	$110.64 - $159.4 $10.2 Million - $14.7 Million	91,909 Added 104.04%	180,250 $23.6 Million

Q3 2021 Nov 09, 2021	BUY	$101.2 - $125.87 $8.94 Million - $11.1 Million	88,341 New	88,341 $10.8 Million

333K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Jennison Associates LLC with notifications on news.